StockData
Cardiol Therapeutics Inc. logo

Cardiol Therapeutics Inc. (CRDL) stock

CRDLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$0.86−0.02 (-2.28%)

Close on Nov 20, 2026Market cap $86.48MP/E –Yield –

Cardiol Therapeutics cash

Cash and short-term investments held at the end of each period.

Cardiol Therapeutics's cash was C$21.42M at Dec 31, 2025. For fiscal 2025 it was C$21.42M, down 30.0% from the year before. The highest annual figure on record is C$83.90M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025C$21.42M-30.0%
FY2024Dec 31, 2024C$30.58M-12.5%
FY2023Dec 31, 2023C$34.93M-41.3%
FY2022Dec 31, 2022C$59.47M-29.1%
FY2021Dec 31, 2021C$83.90M+498.2%
FY2020Dec 31, 2020C$14.03M+101.6%
FY2019Dec 31, 2019C$6.96M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025C$21.42M-74.5%
Q4 FY2024Dec 31, 2024C$30.58M+118.0%
Q4 FY2023Dec 31, 2023C$34.93M+402.2%
Q4 FY2022Dec 31, 2022C$59.47M–
Q4 FY2021Dec 31, 2021C$83.90M–
Q4 FY2020Dec 31, 2020C$14.03M–
Q4 FY2019Dec 31, 2019C$6.96M–

More Cardiol Therapeutics figures

See a number that looks wrong?